Explore the Potential with AI-Driven Innovation
This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.
From a virtual chemical space containing more than 60 billion molecules, we precisely choose certain compounds. Our collaborator, Reaxense, aids in their synthesis and provision.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
Our high-tech, dedicated method is applied to construct targeted libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
It includes comprehensive molecular simulations of the catalytic and allosteric binding pockets and the ensemble virtual screening accounting for their conformational mobility. In the case of designing modulators, the structural changes induced by reaction intermediates are taken into account to leverage activity and selectivity.
Our library distinguishes itself through several key aspects:
partner
Reaxense
upacc
P35790
UPID:
CHKA_HUMAN
Alternative names:
CHETK-alpha; Ethanolamine kinase
Alternative UPACC:
P35790; Q8NE29
Background:
Choline kinase alpha (CHKA), also known as CHETK-alpha and Ethanolamine kinase, is pivotal in phospholipid biosynthesis. It catalyzes the phosphorylation of choline to phosphocholine, a critical step in phosphatidylcholine production. CHKA also contributes to phosphatidylethanolamine biosynthesis by phosphorylating ethanolamine. Its activity is notably higher with choline. Furthermore, CHKA plays a significant role in lipolysis of lipid droplets under glucose deprivation, indicating its involvement in cellular energy management.
Therapeutic significance:
CHKA is linked to a neurodevelopmental disorder characterized by severe developmental delay, microcephaly, and seizures. This association underscores its potential as a target for therapeutic intervention in genetic disorders affecting neurodevelopment. Understanding the role of Choline kinase alpha could open doors to potential therapeutic strategies.